查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2134015

重組人類膠質細胞成熟因子BETA市場：按類型、應用、分銷、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026-2033年預測

Recombinant Human Glial Maturation Factor Beta Market, By Type, By Application, By Distribution, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，全球重組人類膠質細胞成熟因子 BETA 的市值將達到 1.409 億美元，並將在 2026 年至 2033 年期間以 6.5% 的複合年成長率成長。

重組人類膠質成熟因子BETA (GMFB) 是一種研究蛋白，其研究重點在於實驗室合成的人類 GMFB，用於研究肌動蛋白重塑以及神經、膠質細胞、發炎、再生和疾病的機制。人類 GMFB 是一種檢驗的142 個胺基酸的蛋白質，由位於 14q22.2 染色體上的 GMFB 基因編碼，包含一個參與肌動蛋白絲調控的 ADF 同源結構域。該市場與更廣泛的生長因子市場有所不同，因為 GMFB 主要作為專門的分子研究試劑供應，而非傳統的治療或臨床產品。因此，其需求受實驗可重複性、表現系統、純度、內毒素、序列準確性和相容性等因素驅動。到 2025 年，GMFB 研究擴展到肝臟再生、糖尿病視網膜病變和代謝性疾病領域，顯示其研究重要性正在超越傳統的神經生物學應用。

重組人類膠質細胞成熟因子BETA市場－市場動態

GMFB研究拓展至傳統神經生物學之外

推動需求成長的關鍵因素之一是GMFB在疾病機制中日益凸顯的實驗作用，其作用已超越了傳統神經生物學的範疇。到2025年，同儕審查的文獻將表明，該蛋白至少在三種不同的適應症中被研究：肝臟再生、糖尿病視網膜病變和胰島素阻抗，分別證實其與肝細胞增殖、溶酶體功能障礙和脂肪細胞脂質代謝相關。這種多樣化的應用正將採購需求從單純的神經生物學試劑轉變為適用於細胞、組織和疾病模型實驗的多功能蛋白。因此，供應商在序列準確性、純度、表達平台以及確保基於機制的檢測方法可重複性的文件方面展開競爭。其意義顯而易見：對GMFB生物學認知的不斷深入，正在推動利用重組人蛋白作為受控研究材料的實驗流程數量的成長。

重組人類膠質細胞成熟因子BETA市場－市場區隔分析：

全球重組人類膠質細胞成熟因子BETA市場按類型、應用、分銷和地區進行細分。

就類型而言，純度是商業性指標。這是因為GMFB實驗，尤其是在使用重組材料的細胞分析中，常常會受到外源蛋白、聚集、內毒素以及批間差異的影響。純度低於95%的產品適用於將蛋白質用作探針的探索性生化研究，而純度高於95%的產品則更適用於旨在闡明機制的細胞研究。顯然，供應商會根據不同的應用場景提供這兩種純度選擇。例如，根據2025年1月的資料表，Novus Biologicals提供的重組人GMF-BETA蛋白純度高於98%，而其他供應商提供的GMFB純度高於95%。因此，純度如今更多是實驗考量因素，而非產品目錄分類。

從應用角度來看，由於細胞骨架、神經生物學、發炎和疾病研究領域研究的複雜性和方法的廣泛性，商業環境中應用的多樣性而非單一方法佔據主導地位。學術機構和研究中心非常適合進行機制、生物學和疾病相關性方面的研究，而診斷檢查室則可能進行與生物標記相關的研究。生物技術和製藥公司也可能對探索GMFB的治療潛力感興趣。 2025年美國國立衛生研究院（NIH）的預算進一步印證了該研究領域的重要性，其中包括根據其神經科學貸款償還計劃，向國家神經疾病與卒中研究所（NINDS）撥款63項津貼，用於2025會計年度。因此，應用的分佈反映了各公司所處環境和研究主題的差異。

重組人類膠質細胞成熟因子BETA (GMFB) 市場－區域分析

北美仍然是一個重要的市場，這得益於其強大的生物醫學研究基礎設施和豐富的公共資助神經科學研究。根據美國國立衛生研究院 (NIH) 2025 財政年度的調查，美國共授予 39,239 項研究計畫津貼，佔所有研究津貼的 80%。雖然這些數據並未明確提及 GMFB，但如此龐大的津貼規模表明，將相關的重組蛋白納入分子、細胞或疾病模型研究具有巨大的潛力。因此，北美對 GMFB 的主要意義在於其擁有眾多渴望嘗試新型生技藥品的研究機構。對於供應商而言，這意味著滿足嚴格的研究級文件要求、保持批次間品管的一致性以及確保能夠透過既定的分銷管道獲得實驗試劑，是成功的關鍵因素。

亞太地區的一個關鍵特徵是，中國及其他區域研究中心所進行的涉及GMFB基因調控的實驗研究數量不斷增加。 2025年，南方醫科大學發表了一篇預印本，詳細介紹了利用斑馬魚模型進行的肝細胞特異性基因敲低實驗，並將GMFB與肝臟再生和代謝性肝病路徑聯繫起來。在機構層面，華南師範大學報告稱，2025年共有128個計畫津貼國家自然科學基金（NSFC）資助，其中包括58個一般津貼和57個青年科學家基金C津貼。這些例子表明，一個有能力利用專業重組蛋白進行各種實驗研究的買家群體正在崛起。從區域角度來看，由於亞太地區持續產生新的實驗研究需求，該地區正成為GMFB的重要市場。

目錄

第1章：重組人類膠質細胞成熟因子BETA市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：重組人類膠質細胞成熟因子BETA市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：重組人類膠質細胞成熟因子BETA的工業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 重組人類膠質細胞成熟因子BETA市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：重組人類膠質細胞成熟因子BETA的市場趨勢

  • 重組人類膠質細胞成熟因子BETA市場佔有率分析，2025年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 重組人類膠質細胞成熟因子BETA市場：依類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類型
    • 純度低於95%
    • 純度95%或以上

第8章 重組人類膠質細胞成熟因子BETA市場：依應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 學術機構
    • 研究中心
    • 診斷檢查室
    • 製藥和生物技術公司
    • 其他

第9章 重組人類膠質細胞成熟因子BETA市場：依分銷管道分類

  • 概述
    • 基於細分市場的市場佔有率分析：按分銷管道分類
    • 銷售代理
    • 直銷
    • 線上銷售/電子商務

第10章 重組人類膠質細胞成熟因子BETA市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：重組人類膠質細胞成熟因子BETA產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Thermo Fisher Scientific Inc.（PeproTech）
    • Bio-Techne Corporation（R&D Systems）
    • Sino Biological Inc.
    • Abcam plc
    • Novoprotein Scientific Inc.
    • ProSpec-Tany TechnoGene Ltd.
    • RayBiotech, Inc.
    • Creative BioMart
    • Cusabio Technology LLC
    • BPS Bioscience, Inc.
    • Cloud-Clone Corp.
    • GenScript Biotech Corporation
    • ACROBiosystems
    • OriGene Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Elabscience Biotechnology Inc.
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7438

Recombinant Human Glial Maturation Factor Beta Market size was valued at US$ 140.9 Million in 2025, expanding at a CAGR of 6.5% from 2026 to 2033.

Recombinant human glial maturation factor beta (GMFB) is a research use protein market focused on laboratory synthesized human GMFB for studying actin remodeling and neural, glial, inflammatory, regenerative, and disease mechanisms. Human GMFB is a validated 142 amino acid protein encoded by the gene GMFB on chromosome 14q22.2, which contains an ADF homology domain involved in actin filament regulation. The market is distinct from the larger growth factor markets because GMFB is primarily supplied as a specialized molecular research reagent and not as a conventional therapeutic or clinical product. As a result, demand is driven by factors such as experimental reproducibility, expression system, purity, endotoxin, sequence fidelity, and compatibility. The 2025 expansion of GMFB research into liver regeneration, diabetic retinopathy, and metabolic disease suggests that its research relevance is expanding beyond traditional neurobiological applications.

Recombinant Human Glial Maturation Factor Beta Market- Market Dynamics

Expansion of GMFB Research Beyond Conventional Neurobiology

A significant demand driver is the emerging experimental role of GMFB in disease mechanisms beyond its classical neurobiological realm. In 2025, peer-reviewed literature investigated the protein in at least three distinct indications-liver regeneration, diabetic retinopathy, and insulin resistance-linking GMFB to hepatocyte proliferation, lysosomal dysfunction, and adipocyte lipid metabolism, respectively. This diversification transforms the purchasing requirement from a neurobiological reagent into a multi-use protein amenable to cellular, tissue, and disease model experimentation. As such, suppliers compete on sequence fidelity, purity, expression platform, and documentation enabling mechanistic assay reproduction. The implication is specific: expanded GMFB biology increases the number of experimental workflows in which recombinant human protein may serve as a controlled research input.

Recombinant Human Glial Maturation Factor Beta Market- Segmentation Analysis:

The Global Recombinant Human Glial Maturation Factor Beta Market is segmented on the basis of Type, Application, Distribution, and Region.

By type, purity is a commercial indicator because GMFB experiments often depend on the presence of foreign proteins, aggregation, endotoxin, and lot-to-lot variation, especially when dealing with cellular assays of any recombinant material. Purity <95% satisfies exploratory biochemical research, in which the protein is used as a probe, while purity >=95% is more relevant to mechanistic, cell-based studies. It is evident that suppliers offer a choice between the two options due to their different applications. For instance, according to the January 2025 datasheet, Novus Biologicals provides a recombinant human GMF-beta protein with purity >98%, while other suppliers offer human GMFB with purity >=95%. Therefore, purity is now more of an experimental consideration than a catalog classification.

By application, application diversity dominates the commercial environment due to varying levels of research complexity and the range of approaches to the study of the cytoskeleton, neurobiology, inflammation, and disease rather than one specific method dominating the others. Academic institutions and research centers are more suitable for studying mechanisms, biology, and disease relationships, while diagnostic labs may perform studies related to biomarkers; biotech and pharma companies may be interested in exploring the therapeutic potential of GMFB. The research area can be justified by the 2025 NIH budget, of which the National Institute of Neurological Disorders and Stroke's budget is allocated 63 awards in the FY2025 Loan Repayment Program for Neuroscience. Therefore, the application breakdown reflects the differences in the corporate environments and research challenges addressed.

Recombinant Human Glial Maturation Factor Beta Market- Geographical Insights

North America continues to be a major market due to the combined efforts of a robust biomedical research infrastructure and a deep pool of publicly funded neurological studies. According to the NIH's FY2025 survey, there were 39,239 Research Project Grant awards in the U.S., with research project grants accounting for 80% of all research grants. While these figures do not explicitly mention GMFB, the volume of research activity indicates the potential for incorporating relevant recombinant proteins into molecular, cellular, or disease model studies. Thus, North America's primary significance for GMFB lies in the presence of numerous research organizations willing to experiment with novel biologics. For suppliers, this suggests that meeting rigorous research-grade documentation requirements, consistent lot quality control, and access to established laboratory reagent distribution channels are critical success factors.

Asia-Pacific's primary distinction is the growing number of experimental studies conducted within China and other regional research hubs that involve GMFB gene modulation. In 2025, Southern Medical University published a preprint detailing hepatocyte-specific gene knockdown experiments in zebrafish models, linking GMFB to liver regeneration and metabolic liver disease pathways. At the institutional level, South China Normal University reported 128 NSFC-funded projects in 2025, including 58 General Program grants and 57 Young Scientists Fund Class C awards. These examples illustrate the emergence of a qualified buyer base capable of adopting specialized recombinant proteins for various experimental purposes. From a regional perspective, Asia-Pacific is an important market for GMFB due to its rising capacity to generate novel experimental research needs.

Recombinant Human Glial Maturation Factor Beta Market- Competitive Landscape:

Competition is fragmented around technical specifications rather than large-scale product differentiation. Novus Biologicals stresses highly purified E. coli-derived recombinant GMF-beta, while MedChemExpress lists human GMFB products at >=95% purity; OriGene differs by both E. coli and HEK293T expression formats, and Abnova supplies GMFB-related research reagents produced through alternative expression approaches. The competitive field, therefore, spans at least three different expression approaches: bacterial, mammalian, and wheat-germ systems, thus offering buyers options according to experimental requirements. Abcam's GMFB product listing was also updated in August 2025 and provides both 100- and 500-µg formats, thus illustrating continued catalog maintenance. Competitive advantage, therefore, depends upon purity assurance, expression system suitability, formulation, applicability documentation, and reproducibility.

Recent Developments:

In July 2025, a research team from Southern Medical University published a study revealing that hepatocyte GMFB regulates liver regeneration and metabolic liver disease. Three zebrafish groups, including hepatocyte-specific GMFB knockout, GMFB overexpression, and wild-type, were used in the experiment. The experiment involved comparing the liver injury and metabolic disease models.

In August 2025, Tongji University School of Medicine researchers identified that GMFB plays a systemic role in regulating insulin resistance and studied the relationship between GMFB and CARM1 in adipocyte lipid metabolism. The research controlled the biological behaviors of GMFB in rats, mice, and human cells and discovered DS19, which could be a possible GMFB inhibitor.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc. (PeproTech)
  • Bio-Techne Corporation (R&D Systems)
  • Sino Biological Inc.
  • Abcam plc
  • Novoprotein Scientific Inc.
  • ProSpec-Tany TechnoGene Ltd.
  • RayBiotech, Inc.
  • Creative BioMart
  • Cusabio Technology LLC
  • BPS Bioscience, Inc.
  • Cloud-Clone Corp.
  • GenScript Biotech Corporation
  • ACROBiosystems
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Elabscience Biotechnology Inc.
  • Others

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Purity <95%
  • Purity >=95%

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Academic Institutions
  • Research Centers
  • Diagnostic Laboratories
  • Pharmaceutical & Biotech Companies
  • Others

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2020 - 2033

  • Distributors
  • Direct Sales
  • Online Sales/E-commerce

GLOBAL RECOMBINANT HUMAN GLIAL MATURATION FACTOR BETA MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Recombinant Human Glial Maturation Factor Beta Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Recombinant Human Glial Maturation Factor Beta Key Market Trends

  • 3.1. Recombinant Human Glial Maturation Factor Beta Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Recombinant Human Glial Maturation Factor Beta Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Recombinant Human Glial Maturation Factor Beta Market Opportunities
  • 3.4. Recombinant Human Glial Maturation Factor Beta Market Future Trends

4. Recombinant Human Glial Maturation Factor Beta Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Recombinant Human Glial Maturation Factor Beta Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Recombinant Human Glial Maturation Factor Beta Market Landscape

  • 6.1. Recombinant Human Glial Maturation Factor Beta Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Recombinant Human Glial Maturation Factor Beta Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Purity <95%
    • 7.1.3. Purity >=95%

8. Recombinant Human Glial Maturation Factor Beta Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Academic Institutions
    • 8.1.3. Research Centers
    • 8.1.4. Diagnostic Laboratories
    • 8.1.5. Pharmaceutical & Biotech Companies
    • 8.1.6. Others

9. Recombinant Human Glial Maturation Factor Beta Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2025 & 2033 (%)
    • 9.1.2. Distributors
    • 9.1.3. Direct Sales
    • 9.1.4. Online Sales/E-commerce

10. Recombinant Human Glial Maturation Factor Beta Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Recombinant Human Glial Maturation Factor Beta Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Distribution, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Recombinant Human Glial Maturation Factor Beta Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc. (PeproTech)
    • 11.2.2. Bio-Techne Corporation (R&D Systems)
    • 11.2.3. Sino Biological Inc.
    • 11.2.4. Abcam plc
    • 11.2.5. Novoprotein Scientific Inc.
    • 11.2.6. ProSpec-Tany TechnoGene Ltd.
    • 11.2.7. RayBiotech, Inc.
    • 11.2.8. Creative BioMart
    • 11.2.9. Cusabio Technology LLC
    • 11.2.10. BPS Bioscience, Inc.
    • 11.2.11. Cloud-Clone Corp.
    • 11.2.12. GenScript Biotech Corporation
    • 11.2.13. ACROBiosystems
    • 11.2.14. OriGene Technologies, Inc.
    • 11.2.15. Bio-Rad Laboratories, Inc.
    • 11.2.16. Elabscience Biotechnology Inc.
    • 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us